MSF treats patients with a liposomal Amphotericin B, sold by Gilead under the brand name AmBisome.
Press release |

Following a breakthrough in treatment of HIV-related cryptococcal meningitis, MSF urges Gilead to immediately scale up access to lifesaving drug L-AmB

Read more
Photograph by Misha Friedman

Latest news

What good is a breakthrough medicine if the people who need it can't afford it?